SynthesisClinical and experimental medicine2025

Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: a systematic review of monoclonal antibodies and fusion proteins in combination strategies.

Wajahat Mirza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.